Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21(26):7933–43.

Article  PubMed  PubMed Central  Google Scholar 

Baba Y, Nomoto D, Okadome K, et al. Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma. Cancer Sci. 2020;111(9):3132–41.

Article  PubMed  PubMed Central  Google Scholar 

Baba Y, Yoshida N, Kinoshita K, et al. Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study. Ann Surg. 2018;267(3:478–83.

Article  Google Scholar 

Reichenbach ZW, Murray MG, Saxena R, et al. Clinical and translational advances in esophageal squamous cell carcinoma. Adv. Cancer Res. 2019;144:95–135.

Article  Google Scholar 

Harada K, Baba Y, Ishimoto T, et al. The role of microRNA in esophageal squamous cell carcinoma. J Gastroenterol. 2016;51(6):520–30.

Article  PubMed  Google Scholar 

Drahos J, Schwameis K, Orzolek LD, et al. MicroRNA Profiles of Barrett’s Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium. Cancer Epidemiol Biomarkers Prev. 2016;25(3):429–37.

Article  PubMed  Google Scholar 

Sakai NS, Samia-Aly E, Barbera M, et al. A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol. 2013;23(6 Pt B:512–21.

Article  Google Scholar 

Mohammadi E, Aliarab A, Babaei G, et al. MicroRNAs in esophageal squamous cell carcinoma: Application in prognosis, diagnosis, and drug delivery. Pathol Res Pract. 2022;240:154196.

Article  PubMed  Google Scholar 

Zheng LJ, Qu YH, Li SL, et al. The suppressive effects of microRNA-139-5p on proliferation and invasion of esophageal squamous cell carcinoma. Zhonghua Yi Xue Za Zhi. 2021;101(13):956–65.

PubMed  Google Scholar 

Zhang Y, Zhang Y, Ai B, et al. GTF2E2 is a novel biomarker for recurrence after surgery and promotes progression of esophageal squamous cell carcinoma via miR-139-5p/GTF2E2/FUS axis. Oncogene. 2022;41(6):782–96.

Article  PubMed  Google Scholar 

Kong L, Yu Y, Guan H, et al. TGIF1 plays a carcinogenic role in esophageal squamous cell carcinoma through the Wnt/beta-catenin and Akt/mTOR signaling pathways. Int J Mol Med. 2021;47(5).

Guca E, Sunol D, Ruiz L, et al. TGIF1 homeodomain interacts with Smad MH1 domain and represses TGF-beta signaling. Nucleic Acids Res. 2018;46(17):9220–35.

Article  PubMed  PubMed Central  Google Scholar 

Nishimura T, Tamaoki M, Komatsuzaki R, et al. SIX1 maintains tumor basal cells via transforming growth factor-beta pathway and associates with poor prognosis in esophageal cancer. Cancer Sci. 2017;108(2):216–25.

Article  PubMed  PubMed Central  Google Scholar 

Singh V, Singh AP, Sharma I, et al. Epigenetic deregulations of Wnt/beta-catenin and transforming growth factor beta-Smad pathways in esophageal cancer: Outcome of DNA methylation. J Cancer Res Ther. 2019;15(1):192–203.

Article  PubMed  Google Scholar 

Zhao Y, Zhu J, Shi B, et al. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-beta signaling pathway in esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2019;38(1):304.

Article  PubMed  PubMed Central  Google Scholar 

Ren C, Zhou Z, Wang X, et al. SHCBP1 Promotes the Progression of Esophageal Squamous Cell Carcinoma Via the TGFbeta Pathway. Appl Immunohistochem Mol Morphol. 2021;29(2):136–43.

Article  PubMed  Google Scholar 

Wei K, Pan C, Yao G, et al. MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer. Cell Physiol Biochem. 2017;44(4):1545–58.

Article  PubMed  Google Scholar 

Yang Y, Zhang Y, Lin Z, et al. Silencing of histone deacetylase 3 suppresses the development of esophageal squamous cell carcinoma through regulation of miR-494-mediated TGIF1. Cancer Cell Int. 2022;22(1):191.

Article  PubMed  PubMed Central  Google Scholar 

Yang F, Sun Z, Wang D, et al. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD. Bmc Cancer. 2022;22(1):308.

Article  PubMed  PubMed Central  Google Scholar 

Yang T, Hui R, Nouws J, et al. Untargeted metabolomics analysis of esophageal squamous cell cancer progression. J Transl Med. 2022;20(1):127.

Article  PubMed  PubMed Central  Google Scholar 

Kano M, Seki N, Kikkawa N, et al. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer. 2010;127(12):2804–14.

Article  PubMed  Google Scholar 

Liu R, Yang M, Meng Y, et al. Tumor-suppressive function of miR-139-5p in esophageal squamous cell carcinoma. Plos One. 2013;8(10):e77068.

Article  PubMed  PubMed Central  Google Scholar 

Wang B, Ma Q, Wang X, et al. TGIF1 overexpression promotes glioma progression and worsens patient prognosis. Cancer Med. 2022;11(24):5113–28.

Article  PubMed  PubMed Central  Google Scholar 

Li J, Hu M, Liu N, et al. HDAC3 deteriorates colorectal cancer progression via microRNA-296-3p/TGIF1/TGFbeta axis. J Exp Clin Cancer Res. 2020;39(1:248.

Article  Google Scholar 

Ju Q, Jiang M, Huang W, et al. CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/beta-catenin pathway. Oncol Rep. 2022;47(2).

Wang JL, Qi Z, Li YH, et al. TGFbeta induced factor homeobox 1 promotes colorectal cancer development through activating Wnt/beta-catenin signaling. Oncotarget. 2017;8(41):70214–25.

Article  PubMed  PubMed Central  Google Scholar 

Xiang G, Yi Y, Weiwei H, et al. TGIF1 promoted the growth and migration of cancer cells in nonsmall cell lung cancer. Tumour Biol. 2015;36(12):9303–10.

Article  PubMed  Google Scholar